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Introduction
In August 2006, the Hong Kong Law Reform 
Commission (HKLRC) issued its final report on 
‘Substituted Decision-Making and Advanced 
Directives in Relation to Medical Treatment’ and 
endorsed and recommended the use of ‘living 
wills’ to allow individuals who are terminally ill, 
irreversibly comatose or in persistent vegetative 
states, and are mentally incapacitated to refuse life-
sustaining treatments and make treatment choices 
for themselves.1
 There are two popular forms of advance 
directive. The first type, exemplified by living wills, 
is a written directive specifying what treatments 
patients will accept or reject in particular situations 
when they have lost decision-making capacity. The 
second type, called “durable power of attorney for 
healthcare” (DPAHC), is a proxy directive appointing 
and empowering a proxy to either (i) interpret and 
implement the patient’s written or oral instructions 
or (ii) in the absence of any prior instructions make 
health care decisions based on the patient’s known 
values and goals, or in the patient’s best interests, 
or both. The HKLRC has rejected DPAHC for fear of 
“exploitation and abuse” and recommended written 
living wills exclusively.
Can living wills enhance patient 
autonomy?
Since both living wills and conventional informed 
consent share the same moral objective, respect 
for patient autonomy, the ethical standard used for 
informed consent can be used to evaluate living 
wills. In informed consent, doctors give patients 
information about their health and the treatment 
options available to them. Patients must be able to 
rationally assess the risks and benefits of accepting 
or rejecting treatments based on their own values 
and life-goals, and to voluntarily make a decision in 
the context of their medical predicament. Patients 
should also be given time to consider, reconsider, 
and if necessary modify or reverse the decision 
made.
 In living wills, patients are asked to understand 
ill-specified future situations and to reject certain 
treatments in those situations. The HKLRC gives this 
model: “If I become terminally ill or if I am in a state 
of irreversible coma or in a persistent vegetative 
state..., my wishes...are as follows...”2 It then 
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forward
defines ‘terminally ill’ as “suffering from advanced, 
progressive, and irreversible disease, and failing 
to respond to curative therapy, having a short life 
expectancy in terms of days, weeks or a few months; 
and the application of life-sustaining treatment would 
only serve to postpone the moment of death...”.2 
Imagine a 93-year-old patient with chronic congestive 
heart failure with episodic exacerbations, generalised 
crippling osteoarthritis, and carcinoma of the prostate 
with metastases. In what sense is he ‘terminally ill’ 
in the context of the living will? Living wills have 
limited ability to unambiguously specify particular 
illnesses as terminal ones for which patients reject 
treatments. Likewise, ‘irreversibly comatose’ and 
‘persistent vegetative state’ are complex concepts 
that mean different things to different people. 
Furthermore, experience with informed consent 
indicates patients generally know very little about 
illnesses and treatments, and, even when asked to 
choose concrete, identifiable interventions for real-
time medical conditions, are uncertain and hesitant. 
In living wills, choices are much more difficult 
because patients are asked to make decisions about 
future, unspecifiable, and unpredictable events. 
Without assurance that patients can adequately 
consider particular situations stated in living wills, 
their decisions to reject particular treatments could 
not be considered informed.
 Living wills do not define ‘life-sustaining 
treatments’ clearly. The HKLRC defines them as 
“treatments which have the potential to postpone 
the patient’s death and includes...cardiopulmonary 
resuscitation, artificial ventilation, blood products...
antibiotics...and artificial nutrition and hydration.”3 
Arguably, whether a treatment is life-sustaining or 
‘death-postponing’ has more to do with patients’ 
medical conditions than the nature of the treatments 
themselves, and since, in living wills conditions 
are hypothetical and uncertain and treatments 
can at best be tentatively specified, it is technically 
difficult and morally risky to ask patients to judge 
that particular treatments are to be withheld. In 
the previous example, if the 93-year-old man wants 
cardiopulmonary resuscitation withheld for his 
“terminal illnesses”, does it apply if he unexpectedly 
develops cardiac arrest during minor dental surgery? 
Furthermore, it is difficult for patients or even 
doctors to weigh the risks/benefits of treatments 
since information about their success/failure rates 
or short-/long-term consequences are seldom fully 
known. For example, many patients do not know that 
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the artificial nutrition and hydration they may reject 
in a living will are the only treatments that keep them 
alive. Patients seldom make decisions under optimal 
conditions when making living wills. Life and death 
decisions do not depend solely on “...the calculus 
of rational considerations. [They]...also include 
assessment of emotions, desires, fears, and other 
feelings that cannot possibly be made, except in the 
actual presence of those sentiments.”4 When making 
living wills, patients are not actually confronting real 
situations and thus process abstract information in 
an emotional vacuum, making decisions that are not 
authentic choices. If conventional informed consent 
standards are used as our ethical benchmark, most 
living wills are uninformed or under-informed health 
care directives. They undermine rather than promote 
patient autonomy.
overseas experience
Overseas studies have found that not only are patients 
reluctant to make living wills, when they do, their 
stated preferences may not be genuine. In the United 
States, after the Patient Self-Determination Act was 
passed in 1990, the number of people executing living 
wills remained unchanged at 15% to 20%. Others 
have reported that doctors, patients and their families 
interpret the terms in living wills very differently,5 
and patients often issue inconsistent instructions. 
For example, some patients accept cardiopulmonary 
resuscitation, even when survival chances are low, 
but simultaneously reject mechanical ventilation 
under all circumstances.6
Some potential benefits of living wills
Living wills are not without potential benefits. They 
provide comfort and confidence for patients and their 
families, relieve relatives of the burden of making 
critical decisions, and reduce disputes among family 
members. But the most significant benefit living wills 
can potentially bring is a reduction in health care costs. 
Despite some early studies that found no connection 
between the use of living wills and health care 
savings,7-9 some more recent, better-designed studies 
have found the reverse. A randomised controlled 
trial involving 1292 residents in six Canadian nursing 
homes found that those facilities promoting living 
wills had fewer hospitalisations per resident (0.27 vs 
0.48) and lower health care costs per resident (Can 
$3490 vs Can $5239).10 A retrospective study of 336 
patients who died in a US university hospital found 
that patients with living wills spent less than 3 days 
in intensive care unit while those with none spent 
over 5 days and their hospital charges were 1.35 
times higher (US $49 900 vs US $31 200).11 Another 
recent mortality follow-back survey found that the 
use of living wills is associated with less use of life-
sustaining treatment, greater use of hospices, and 
less likelihood of terminal hospitalisation.12 Given 
the importance of controlling health care costs, the 
ethical significance of this use of living wills cannot 
be underestimated.
the way forward
The use of living wills poses a dilemma. On the one 
hand, living wills serve patient autonomy poorly; 
on the other hand, living wills have the advantage 
of reducing health care costs. Yet, moral persons 
ought not to cut health care costs at the expense of 
patient autonomy. One way to resolve this dilemma 
and move forward is to use living wills as occasions 
for doctors to engage in full and open discussions 
with terminally ill patients and families so that the 
living wills that emerge from these dialogues fully 
reflect patients’ understanding, values, needs, and 
preferences.13 Thus living wills may become fully 
informed instruments and patient autonomy is 
preserved. A terminal illness involves all aspects of 
patients’ lives including physical, psychological, social, 
relational, and spiritual dimensions, thus their needs 
are also multi-dimensional. This implies that dying is 
not an exclusively medical experience and any ethical 
approach to managing terminally ill patients must 
go beyond the conventional bio-medical paradigm. 
Sadly, modern ethics and law narrowly construe 
living wills as tools ensuring patient autonomy in 
medical decision-making. Yet, autonomy is not the 
only value taken into consideration by terminally ill 
patients. In one US study of 646 seriously ill adult in-
patients and 513 older in-patients, 78.0% and 70.8% 
respectively said they preferred to leave it to their 
family or physicians to decide whether to give them 
cardiopulmonary resuscitation rather than make a 
living will.14
 In sum, end-of-life patients either need to better 
understand medical issues in their unique contexts 
and hence make decisions that are consistent with 
their values and goals, or forego their autonomy 
and depend on significant others to make decisions 
for them. Preparing under-informed and poorly 
understood living wills not only undermines patient 
autonomy but, more importantly, fails to capture 
patients’ real needs. Most terminally ill patients 
see living wills as a means of preparing for death 
and dying, processes where personal values, family 
relationships, cultural conventions, and religious 
beliefs count far more than exercising autonomy. 
Making a living will allows doctors and patients to 
talk about death and dying and opens the door to a 
positive, caring approach to end-of-life patients. To 
do anything less is to underestimate the complexity 
of end-of-life decision-making and to miss the 
opportunity to understand and meet the multi-
dimensional needs of end-of-life patients.
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